pirodavir has been researched along with Poliomyelitis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chaltin, P; De Palma, A; Koukni, M; Leyssen, P; Marchand, A; Martin, J; Neyts, J; Oberste, S; PĆ¼rstinger, G; Rhoden, E; Spieser, SA; Thibaut, HJ; Tijsma, A; Volny-Luraghi, A | 1 |
1 other study(ies) available for pirodavir and Poliomyelitis
Article | Year |
---|---|
H1PVAT is a novel and potent early-stage inhibitor of poliovirus replication that targets VP1.
Topics: Amino Acid Substitution; Animals; Antiviral Agents; Base Sequence; Binding Sites; Capsid; Capsid Proteins; Cell Line, Tumor; Chlorocebus aethiops; Drug Resistance, Viral; HeLa Cells; Humans; Models, Molecular; Piperidines; Poliomyelitis; Poliovirus; Pyrazoles; Pyridazines; Pyrimidines; RNA, Viral; Sequence Analysis, RNA; Virus Replication | 2014 |